Multiple agents effective for excessive daytime sleepiness but may be discontinued due to side effects, review finds
A systematic review and meta-analysis of 14 trials found that solriamfetol, armodafinil-modafinil, and pitolisant were associated with reduced daytime sleepiness but also with headache, insomnia, and anxiety in patients with obstructive sleep apnea.
In a pre-post study, a decision support tool that prompted clinicians about appropriate testing criteria and included a best practice advisory was associated with reductions of 44% and 46% in inpatient and outpatient orders and of 61% and 48% in repeat testing, respectively.
A 51-year-old man is evaluated for intermittent, bright red blood per rectum of 10 weeks' duration. Following a physical exam and other tests and imaging of a nonobstructing lesion at 10 cm from the anal verge, what is the most appropriate treatment?
A scientific statement from the American Heart Association/American Stroke Association called for collaboration among primary care physicians, subspecialist doctors, and other health professionals to identify and manage cognitive problems after stroke.
Register now for ACP and Annals of Internal Medicine's forum on the end of the COVID-19 Public Health Emergency
The virtual live event will be held on May 19 from 3:30 to 5 p.m. ET.
Resources include salary data and a contract scorecard and benchmarking tool.